Home Casteddu.com	FAQ My Amedeo About	Flying Publisher
	The Medical Article of the Year 2008

Hepatitis

Free Subscription Articles published in Hepatology Retrieve available abstracts of 304 articles: HTML format

Single Articles

June 2008
1. SHERMAN M , Yurdaydin C, Simsek H, Silva M, et al
   Entecavir therapy for lamivudine-refractory chronic hepatitis B: Improved virologic, biochemical, and serology outcomes through 96 weeks.
   Hepatology. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
2. HARRIS RA , Sugimoto K, Kaplan DE, Ikeda F, et al
   Human leukocyte antigen class II associations with hepatitis C virus clearance and virus-specific CD4 T cell response among Caucasians and African Americans.
   Hepatology. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
3. PHAM TN , Michalak TI
   Hepatitis C virus in peripheral blood mononuclear cells of individuals with isolated anti-hepatitis C virus antibody reactivity.
   Hepatology. 2008;.
   PubMed     Related articles   
   
   
   
4. SCHIAVON LL , Carvalho-Filho RJ, Narciso-Schiavon JL, Barbosa DV, et al
   Impact of cyclosporine-based immunosuppressive therapy on liver histology of hepatitis C virus-infected renal transplant patients.
   Hepatology. 2008;.
   PubMed     Related articles   
   
   
   
5. SANZ-CAMENO P , Martin-Vilchez S, Rodriguez-Munoz Y, Moreno-Otero R, et al
   Implicaton of tetraspanin-enriched microdomains (TEMs) in hepatitis C virus.
   Hepatology. 2008;.
   PubMed     Related articles   
   
   
   May 2008
6. POLYAK SJ , Morishima C, Hawke R
   Antiviral effects of silymarin against hepatitis C: The jury is still out.
   Hepatology. 2008;.
   PubMed     Related articles   
   
   
   
7. MORCOS PN , Brennan B, Smith PF
   A grapefruit a day for patients infected with hepatitis C?
   Hepatology. 2008;47:2141-2142.
   PubMed     Related articles   
   
   
   
8. TORRES DM , Harrison SA
   Insulin resistance in chronic hepatitis C, genotypes 1 and 4: The unfortunate reality.
   Hepatology. 2008;47:2137-2139.
   PubMed     Related articles   
   
   
   
9. YU ML , Dai CY, Huang JF, Chiu CF, et al
   Rapid virological response and treatment duration for chronic hepatitis C genotype 1 patients: A randomized trial.
   Hepatology. 2008;47:1884-1893.
   PubMed     Related articles    Abstract available
   
   
   
10. RIGOPOULOU EI , Dalekos GN
    Autoimmune hepatitis: Of host and pathogen.
    Hepatology. 2008;.
    PubMed     Related articles   
    
    
    
11. GONZALEZ SA , Keeffe EB
    Hepatitis B virus genotype: A missing link in transmission risk and disease progression?
    Hepatology. 2008;47:1788-90.
    PubMed     Related articles   
    
    
    
12. MORENO-OTERO R , Trapero M, Moreno-Monteagudo JA
    Chronic hepatitis C genotype 2 or 3 short treatment.
    Hepatology. 2008;47:1796.
    PubMed     Related articles   
    
    
    
13. TACKE F , Trautwein C
    Hepatitis B goes globe: Telbivudine as a new treatment option.
    Hepatology. 2008;47:1786-7.
    PubMed     Related articles   
    
    
    April 2008
14. THEIN HH , Yi Q, Dore GJ, Krahn MD, et al
    Estimation of stage-specific fibrosis progression rates in chronic hepatitis C virus infection: A meta-analysis and meta-regression.
    Hepatology. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
15. SCHAFER DF
    Chronic genotype 4 hepatitis C.
    Hepatology. 2008;.
    PubMed     Related articles   
    
    
    
16. JACOBSON IM , Brown RS Jr
    WIN-R revisited: Response to editorial.
    Hepatology. 2008;47:1427.
    PubMed     Related articles   
    
    
    March 2008
17. ZEKRY A , Freiman J
    Eltrombopag: Is this "24 karat gold platelet" treatment for thrombocytopenia in cirrhosis associated with hepatitis C?
    Hepatology. 2008;47:1418-1421.
    PubMed     Related articles   
    
    
    
18. EBIHARA T , Shingai M, Matsumoto M, Wakita T, et al
    Hepatitis C virus-infected hepatocytes extrinsically modulate dendritic cell maturation to activate T cells and natural killer cells.
    Hepatology. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
19. EL-SHAMY A , Nagano-Fujii M, Sasase N, Imoto S, et al
    Sequence variation in hepatitis C virus nonstructural protein 5A predicts clinical outcome of pegylated interferon/ribavirin combination therapy.
    Hepatology. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
20. HENNES EM , Zeniya M, Czaja AJ, Pares A, et al
    Simplified criteria for the diagnosis of autoimmune hepatitis.
    Hepatology. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
21. ROBERTS SK , Cooksley G, Dore GJ, Robson R, et al
    Robust antiviral activity of R1626, a novel nucleoside analog: A randomized, placebo-controlled study in patients with chronic hepatitis C.
    Hepatology. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
22. PETTA S , Camma C, Di Marco V, Alessi N, et al
    Retinol-binding protein 4: A new marker of virus-induced steatosis in patients infected with hepatitis c virus genotype 1.
    Hepatology. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
23. OZARAS R , Leblebicioglu H, Eroglu C
    To define virological response in hepatitis B e antigen-negative patients.
    Hepatology. 2008;.
    PubMed     Related articles   
    
    
    
24. SWAN T , Chung RT
    Development of novel agents for the treatment of hepatitis C virus.
    Hepatology. 2008;.
    PubMed     Related articles   
    
    
    
25. ONG SC , Mak B, Aung MO, Li SC, et al
    Health-related quality of life in chronic hepatitis B patients.
    Hepatology. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
26. HERKEL J , Lohse AW
    Significance of autoantibodies.
    Hepatology. 2008;47:786-8.
    PubMed     Related articles   
    
    
    
27. LEE SH , Song R, Lee MN, Kim CS, et al
    A molecular chaperone glucose-regulated protein 94 blocks apoptosis induced by virus infection.
    Hepatology. 2008;47:854-66.
    PubMed     Related articles    Abstract available
    
    
    February 2008
28. ZEISEL MB , Cosset FL, Baumert TF
    Host neutralizing responses and pathogenesis of hepatitis C virus infection.
    Hepatology. 2008;.
    PubMed     Related articles   
    
    
    
29. TAHIRI F , Le Naour F, Huguet S, Lai-Kuen R, et al
    Identification of plasma membrane autoantigens in autoimmune hepatitis type 1 using a proteomics tool.
    Hepatology. 2008;47:937-948.
    PubMed     Related articles    Abstract available
    
    
    
30. BORTOLAMI M , Cardin R, Kotsafti A, Farinati F, et al
    TGF-beta and hepatocellular carcinoma.
    Hepatology. 2008;47:1095.
    PubMed     Related articles   
    
    
    
31. HIASA Y , Kuzuhara H, Tokumoto Y, Konishi I, et al
    Hepatitis C virus replication is inhibited by 22beta-methoxyolean-12-ene-3beta, 24(4beta)-diol (ME3738) through enhancing interferon-beta.
    Hepatology. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
32. WARNER N , Locarnini S
    The antiviral drug selected hepatitis B virus rtA181T/sW172* mutant has a dominant negative secretion defect and alters the typical profile of viral rebound.
    Hepatology. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
33. BEARD MR , Helbig KJ
    Control of HCV replication: When size does not matter.
    Hepatology. 2008;47:1092-1094.
    PubMed     Related articles   
    
    
    
34. FAFI-KREMER S , Stoll-Keller F, Baumert TF
    Efficient postexposure prophylaxis by hepatitis A vaccine.
    Hepatology. 2008;47:1416-1418.
    PubMed     Related articles   
    
    
    
35. SHEIKH MY , Choi J, Qadri I, Friedman JE, et al
    Hepatitis C virus infection: Molecular pathways to metabolic syndrome.
    Hepatology. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
36. MARTIN-VILCHEZ S , Sanz-Cameno P, Rodriguez-Munoz Y, Majano PL, et al
    The hepatitis B virus X protein induces paracrine activation of human hepatic stellate cells.
    Hepatology. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
37. FERENCI P , Brunner H, Laferl H, Scherzer TM, et al
    A randomized, prospective trial of ribavirin 400 mg/day versus 800 mg/day in combination with peginterferon alfa-2a in hepatitis C virus genotypes 2 and 3.
    Hepatology. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
38. FENG D , Zhou F, Wu C
    Leptin, a possible cause for regulatory T cell loss in fatty liver?
    Hepatology. 2008;47:764.
    PubMed     Related articles   
    
    
    
39. GUHA IN , Parkes J, Roderick P, Chattopadhyay D, et al
    Noninvasive markers of fibrosis in nonalcoholic fatty liver disease: Validating the European Liver Fibrosis Panel and exploring simple markers.
    Hepatology. 2008;47:455-60.
    PubMed     Related articles    Abstract available
    
    
    
40. JONAS MM , Kelly D, Pollack H, Mizerski J, et al
    Safety, efficacy, and pharmacokinetics of adefovir dipivoxil in children and adolescents (age 2 to <18 years) with chronic hepatitis B.
    Hepatology. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
41. LAGGING M , Langeland N, Pedersen C, Farkkila M, et al
    Randomized comparison of 12 or 24 weeks of peginterferon alpha-2a and ribavirin in chronic hepatitis C virus genotype 2/3 infection.
    Hepatology. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
42. VELDT BJ , Chen W, Heathcote EJ, Wedemeyer H, et al
    Increased risk of hepatocellular carcinoma among patients with hepatitis C cirrhosis and diabetes mellitus.
    Hepatology. 2008;47:1856-1862.
    PubMed     Related articles    Abstract available
    
    
    January 2008
43. VANWOLLEGHEM T , Bukh J, Meuleman P, Desombere I, et al
    Polyclonal immunoglobulins from a chronic hepatitis C virus patient protect human liver-chimeric mice from infection with a homologous hepatitis C virus strain.
    Hepatology. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
44. NEUMANN-HAEFELIN C , Timm J, Spangenberg HC, Wischniowski N, et al
    Virological and immunological determinants of intrahepatic virus-specific CD8+ T-cell failure in chronic hepatitis C virus infection.
    Hepatology. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
45. KAMAL SM , Nasser IA
    Hepatitis C genotype 4: What we know and what we don't yet know.
    Hepatology. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
46. HSU CS , Kao JH
    Insulin resistance, adipocytokines, and hepatitis C virus infection: A missing link?
    Hepatology. 2008;47:760-761.
    PubMed     Related articles   
    
    
    
47. ADLER M , Gulbis B, Moreno C, Evrard S, et al
    The predictive value of FIB-4 versus FibroTest, APRI, FibroIndex and Forns index to noninvasively estimate fibrosis in hepatitis C and nonhepatitis C liver diseases.
    Hepatology. 2008;47:762-763.
    PubMed     Related articles   
    
    
    
48. VALLET-PICHARD A , Mallet V, Pol S
    Predictive value of FIB-4 versus fibrotest, APRI, FIBROINDEX and FORNS to noninvasively estimate fibrosis in hepatitis C.
    Hepatology. 2008;47:763.
    PubMed     Related articles   
    
    
    
49. FENG D , Xu L
    Lipid accumulation in concanavalin A-induced hepatitis: Another cause for impaired liver regeneration afterwards?
    Hepatology. 2008;47:765.
    PubMed     Related articles   
    
    
    
50. COLSON P , Brouk N, Lembo F, Castellani P, et al
    Natural presence of substitution R155K within hepatitis C virus NS3 protease from a treatment-naive chronically infected patient.
    Hepatology. 2008;47:766-767.
    PubMed     Related articles   
    
    
    
51. COBBOLD JF , Taylor-Robinson SD
    Transient elastography in acute hepatitis: All that's stiff is not fibrosis.
    Hepatology. 2008;47:370-372.
    PubMed     Related articles   
    
    
    
52. BARANOVA A , Younossi ZM
    The future is around the corner: Noninvasive diagnosis of progressive nonalcoholic steatohepatitis.
    Hepatology. 2008;47:373-375.
    PubMed     Related articles   
    
    
    
53. LAU DT , Fish PM, Sinha M, Owen DM, et al
    Interferon regulatory factor-3 activation, hepatic interferon-stimulated gene expression, and immune cell infiltration in hepatitis C virus patients.
    Hepatology. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
54. TORISU T , Nakaya M, Watanabe S, Hashimoto M, et al
    Suppressor of cytokine signaling 1 protects mice against concanavalin A-induced hepatitis by inhibiting apoptosis.
    Hepatology. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
55. TRUJILLO-MURILLO K , Rincon-Sanchez AR, Martinez-Rodriguez H, Bosques-Padilla F, et al
    Acetylsalicylic acid inhibits hepatitis C virus RNA and protein expression through cyclooxygenase 2 signaling pathways.
    Hepatology. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
56. LOUSTAUD-RATTI V , Alain S, Rousseau A, Hubert IF, et al
    Ribavirin exposure after the first dose is predictive of sustained virological response in chronic hepatitis C.
    Hepatology. 2008;47:1453-1461.
    PubMed     Related articles    Abstract available
    
    
    
57. BALDICK CJ , Tenney DJ, Mazzucco CE, Eggers BJ, et al
    Comprehensive evaluation of hepatitis B virus reverse transcriptase substitutions associated with entecavir resistance.
    Hepatology. 2008;47:1473-1482.
    PubMed     Related articles    Abstract available
    
    
    
58. NORTHFIELD JW , Kasprowicz V, Lucas M, Kersting N, et al
    CD161 expression on hepatitis C virus-specific CD8+ T cells suggests a distinct pathway of T cell differentiation.
    Hepatology. 2008;47:396-406.
    PubMed     Related articles    Abstract available
    
    
    
59. FRIED MW , Piratvisuth T, Lau GK, Marcellin P, et al
    HBeAg and hepatitis B virus DNA as outcome predictors during therapy with peginterferon alfa-2a for HBeAg-positive chronic hepatitis B.
    Hepatology. 2008;47:428-434.
    PubMed     Related articles    Abstract available
    
    
    
60. LONGHI MS , Meda F, Wang P, Samyn M, et al
    Expansion and de novo generation of potentially therapeutic regulatory T cells in patients with autoimmune hepatitis.
    Hepatology. 2008;47:581-591.
    PubMed     Related articles    Abstract available
    
    
    
61. FLISIAK R , Horban A, Gallay P, Bobardt M, et al
    The cyclophilin inhibitor Debio-025 shows potent anti-hepatitis C effect in patients coinfected with hepatitis C and human immunodeficiency virus.
    Hepatology. 2008;47:817-826.
    PubMed     Related articles    Abstract available
    
    
    
62. STERLING RK , Contos MJ, Smith PG, Stravitz RT, et al
    Steatohepatitis: Risk factors and impact on disease severity in human immunodeficiency virus/hepatitis C virus coinfection.
    Hepatology. 2008;47:1118-1127.
    PubMed     Related articles    Abstract available
    
    
    
63. NAHMIAS Y , Goldwasser J, Casali M, van Poll D, et al
    Apolipoprotein B-dependent hepatitis C virus secretion is inhibited by the grapefruit flavonoid naringenin.
    Hepatology. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
64. FONTANA RJ , Goodman ZD, Dienstag JL, Bonkovsky HL, et al
    Relationship of serum fibrosis markers with liver fibrosis stage and collagen content in patients with advanced chronic hepatitis C.
    Hepatology. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
65. CHUNG RT , Gale M Jr, Polyak SJ, Lemon SM, et al
    Mechanisms of action of interferon and ribavirin in chronic hepatitis C: Summary of a workshop.
    Hepatology. 2008;47:306-20.
    PubMed     Related articles   
    
    
    
66. SANGIOVANNI A , Iavarone M
    Hepatitis C virus genotype 1b, cirrhosis, and risk of hepatocellular carcinoma.
    Hepatology. 2008;47:357.
    PubMed     Related articles   
    
    
    
67. WOLK B , Wedemeyer H
    Hepatitis C virus living off the fat of the land.
    Hepatology. 2008;47:343-5.
    PubMed     Related articles   
    
    
    
68. RILEY TR 3RD
    Predictors of response of U.S. veterans to treatment for the hepatitis C virus.
    Hepatology. 2008;47:356.
    PubMed     Related articles   
    
    
    
69. MORRA R , Lebray P, Ingiliz P, Ngo Y, et al
    FibroTest has better diagnostic and prognostic values than the aspartate aminotransferase-to-platelet ratio index in patients with chronic hepatitis C.
    Hepatology. 2008;47:353-4.
    PubMed     Related articles   
    
    
    
70. BLACKARD JT , Shata MT, Shire NJ, Sherman KE, et al
    Acute hepatitis C virus infection: a chronic problem.
    Hepatology. 2008;47:321-31.
    PubMed     Related articles   
    
    
    
71. KUROSAKI M , Izumi N
    External validation of FIB-4: diagnostic accuracy is limited in elderly populations.
    Hepatology. 2008;47:352.
    PubMed     Related articles   
    
    
    
72. SHAN W , Nicol CJ, Ito S, Bility MT, et al
    Peroxisome proliferator-activated receptor-beta/delta protects against chemically induced liver toxicity in mice.
    Hepatology. 2008;47:225-35.
    PubMed     Related articles    Abstract available
    
    
    December 2007
73. GOODMAN ZD , Makhlouf HR, Liu L, Balistreri W, et al
    Pathology of chronic hepatitis C in children: Liver biopsy findings in the Peds-C Trial.
    Hepatology. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
74. ABDALIAN R , Dhar P, Jhaveri K, Haider M, et al
    Prevalence of sclerosing cholangitis in adults with autoimmune hepatitis: Evaluating the role of routine magnetic resonance imaging.
    Hepatology. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
75. HSU C , Hsiung CA, Su IJ, Hwang WS, et al
    A revisit of prophylactic lamivudine for chemotherapy-associated hepatitis B reactivation in non-Hodgkin's lymphoma: A randomized trial.
    Hepatology. 2007;47:844-853.
    PubMed     Related articles    Abstract available
    
    
    
76. NISHIDA N , Nagasaka T, Nishimura T, Ikai I, et al
    Aberrant methylation of multiple tumor suppressor genes in aging liver, chronic hepatitis, and hepatocellular carcinoma.
    Hepatology. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
77. SEEFF LB , Curto TM, Szabo G, Everson GT, et al
    Herbal product use by persons enrolled in the hepatitis C Antiviral Long-Term Treatment Against Cirrhosis (HALT-C) Trial.
    Hepatology. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
78. UTOH R , Tateno C, Yamasaki C, Hiraga N, et al
    Susceptibility of chimeric mice with livers repopulated by serially subcultured human hepatocytes to hepatitis B virus.
    Hepatology. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
79. ROMERO-GOMEZ M , Gomez-Gonzalez E, Madrazo A, Vera-Valencia M, et al
    Optical analysis of computed tomography images of the liver predicts fibrosis stage and distribution in chronic hepatitis C.
    Hepatology. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
80. DUCLOS-VALLEE JC , Feray C, Sebagh M, Teicher E, et al
    Survival and recurrence of hepatitis C after liver transplantation in patients coinfected with human immunodeficiency virus and hepatitis C virus.
    Hepatology. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
81. BERNARDIN F , Tobler L, Walsh I, Williams JD, et al
    Clearance of hepatitis C virus RNA from the peripheral blood mononuclear cells of blood donors who spontaneously or therapeutically control their plasma viremia.
    Hepatology. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
82. SAGIR A , Erhardt A, Schmitt M, Haussinger D, et al
    Transient elastography is unreliable for detection of cirrhosis in patients with acute liver damage.
    Hepatology. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
83. GERSHWIN ME , Mackay IR
    The causes of primary biliary cirrhosis: Convenient and inconvenient truths.
    Hepatology. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
84. ARENA U , Vizzutti F, Corti G, Ambu S, et al
    Acute viral hepatitis increases liver stiffness values measured by transient elastography.
    Hepatology. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
85. DHAREL N , Kato N, Muroyama R, Taniguchi H, et al
    Potential contribution of tumor suppressor p53 in the host defense against hepatitis C virus.
    Hepatology. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
86. VARNHOLT H , Drebber U, Schulze F, Wedemeyer I, et al
    MicroRNA gene expression profile of hepatitis C virus-associated hepatocellular carcinoma.
    Hepatology. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
87. WISE M , Bialek S, Finelli L, Bell BP, et al
    Changing trends in hepatitis C-related mortality in the United States, 1995-2004.
    Hepatology. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
88. YU ML , Dai CY, Huang JF, Hsieh MY, et al
    Pegylated interferon alpha-2b plus ribavirin in patients with genotype 4 chronic hepatitis C: Some issues.
    Hepatology. 2007;47:1792-1793.
    PubMed     Related articles   
    
    
    
89. DAI CY , Chuang WL, Huang JF, Hsieh MY, et al
    Possible determinants of rapid virological response suggesting shorter courses of combination therapy for hepatitis C virus genotype 2.
    Hepatology. 2007;.
    PubMed     Related articles   
    
    
    
90. EINAV S , Sklan EH, Moon HM, Gehrig E, et al
    The nucleotide binding motif of hepatitis C virus NS4B can mediate cellular transformation and tumor formation without Ha-ras co-transfection.
    Hepatology. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
91. HOU J , Yin YK, Xu D, Tan D, et al
    Telbivudine versus lamivudine in Chinese patients with chronic hepatitis B: Results at 1 year of a randomized, double-blind trial.
    Hepatology. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
92. REYNOLDS GM , Harris HJ, Jennings A, Hu K, et al
    Hepatitis C virus receptor expression in normal and diseased liver tissue.
    Hepatology. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
93. LIAO G , Wang Y, Chang J, Bian T, et al
    Hepatitis B virus precore protein augments genetic immunizations of the truncated hepatitis C virus core in BALB/c mice.
    Hepatology. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
94. MANGIA A , Minerva N, Bacca D, Cozzolongo R, et al
    Individualized treatment duration for hepatitis C genotype 1 patients: A randomized controlled trial.
    Hepatology. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
95. CHAVEZ-TAPIA NC , Tellez-Avila FI
    Nonalcoholic steatohepatitis in chronic hepatitis C: A new classification?
    Hepatology. 2007;.
    PubMed     Related articles   
    
    
    
96. SHIINA M , Rehermann B
    Cell culture-produced hepatitis C virus impairs plasmacytoid dendritic cell function.
    Hepatology. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
97. HOEFS JC , Morgan TR
    Seventy-two weeks of peginterferon and ribavirin for patients with partial early virologic response?
    Hepatology. 2007;46:1671-4.
    PubMed     Related articles   
    
    
    
98. VAN DER POORTEN D , Kenny DT, Butler T, George J, et al
    Liver disease in adolescents: A cohort study of high-risk individuals.
    Hepatology. 2007;46:1750-8.
    PubMed     Related articles    Abstract available
    
    
    November 2007
99. PEARLMAN BL , Ehleben C, Saifee S
    Treatment extension to 72 weeks of peginterferon and ribavirin in hepatitis c genotype 1-infected slow responders.
    Hepatology. 2007;46:1688-1694.
    PubMed     Related articles    Abstract available
    
    
    
100. SCHULZE A , Gripon P, Urban S
     Hepatitis B virus infection initiates with a large surface protein-dependent binding to heparan sulfate proteoglycans.
     Hepatology. 2007;46:1759-1768.
     PubMed     Related articles    Abstract available
     
     
     
101. TSOCHATZIS E , Papatheodoridis GV, Archimandritis AJ
     Adipokines and insulin resistance in chronic hepatitis C.
     Hepatology. 2007;46:2050-2051.
     PubMed     Related articles   
     
     
     
102. HAMDI H , Bigorgne A, Naveau S, Balian A, et al
     Glucocorticoid-induced leucine zipper: A key protein in the sensitization of monocytes to lipopolysaccharide in alcoholic hepatitis.
     Hepatology. 2007;46:1986-1992.
     PubMed     Related articles    Abstract available
     
     
     
103. KANWAL F , Hoang T, Spiegel BM, Eisen S, et al
     Predictors of treatment in patients with chronic hepatitis C infection-Role of patient versus nonpatient factors.
     Hepatology. 2007;46:1741-1749.
     PubMed     Related articles    Abstract available
     
     
     
104. SHERMAN KE , Fleischer R, Laessig K, Murray J, et al
     Development of novel agents for the treatment of chronic hepatitis C infection: Summary of the FDA Antiviral Products Advisory Committee recommendations.
     Hepatology. 2007;.
     PubMed     Related articles   
     
     
     
105. YUEN MF , Fong DY, Wong DK, Yuen JC, et al
     Hepatitis B virus DNA levels at week 4 of lamivudine treatment predict the 5-year ideal response.
     Hepatology. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
106. KREMER M , Perry AW, Milton RJ, Rippe RA, et al
     Pivotal role of Smad3 in a mouse model of T cell-mediated hepatitis.
     Hepatology. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
107. ZEISEL MB , Koutsoudakis G, Schnober EK, Haberstroh A, et al
     Scavenger receptor class B type I is a key host factor for hepatitis C virus infection required for an entry step closely linked to CD81.
     Hepatology. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
108. YAMAGUCHI K , Yang L, McCall S, Huang J, et al
     Diacylglycerol acyltranferase 1 anti-sense oligonucleotides reduce hepatic fibrosis in mice with nonalcoholic steatohepatitis.
     Hepatology. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
109. DALGARD O , Bjoro K, Ring-Larsen H, Bjornsson E, et al
     Pegylated interferon alfa and ribavirin for 14 versus 24 weeks in patients with hepatitis C virus genotype 2 or 3 and rapid virological response.
     Hepatology. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
110. MALHI H
     TRAILs and tribulation.
     Hepatology. 2007;46:1320-2.
     PubMed     Related articles   
     
     
     
111. MA X , Hua J, Mohamood AR, Hamad AR, et al
     A high-fat diet and regulatory T cells influence susceptibility to endotoxin-induced liver injury.
     Hepatology. 2007;46:1519-29.
     PubMed     Related articles    Abstract available
     
     
     October 2007
112. PAPPAS SC
     Good science behind hepatitis C virus antiviral drug development: Necessary but not sufficient.
     Hepatology. 2007;46:1317-1318.
     PubMed     Related articles   
     
     
     
113. SHACKEL NA , McCaughan GW
     Intrahepatic interferon-stimulated gene responses: Can they predict treatment responses in chronic hepatitis C infection?
     Hepatology. 2007;46:1326-1328.
     PubMed     Related articles   
     
     
     
114. HUO TI , Wu JC, Lee SD
     Does hepatitis B viral load determine the outcome of patients with hepatocellular carcinoma undergoing chemotherapy?
     Hepatology. 2007;46:1665-1666.
     PubMed     Related articles   
     
     
     
115. KAMAL SM , El Kamary SS, Shardell MD, Hashem M, et al
     Pegylated interferon alpha-2b plus ribavirin in patients with genotype 4 chronic hepatitis C: The role of rapid and early virologic response.
     Hepatology. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
116. TIMPE JM , Stamataki Z, Jennings A, Hu K, et al
     Hepatitis C virus cell-cell transmission in hepatoma cells in the presence of neutralizing antibodies.
     Hepatology. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
117. LIU SP , Li YS, Chen YJ, Chiang EP, et al
     Glycine N-methyltransferase-/- mice develop chronic hepatitis and glycogen storage disease in the liver.
     Hepatology. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
118. INOUE K , Watanabe T, Yoshiba M, Kohara M, et al
     Hepatitis C virus RNA kinetics in chimeric mice with human hepatocytes during antiviral therapy.
     Hepatology. 2007;.
     PubMed     Related articles   
     
     
     
119. SOBESKY R , Feray C, Rimlinger F, Derian N, et al
     Distinct hepatitis C virus core and F protein quasispecies in tumoral and nontumoral hepatocytes isolated via microdissection.
     Hepatology. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
120. HRABER P , Kuiken C, Yusim K
     Evidence for human leukocyte antigen heterozygote advantage against hepatitis C virus infection.
     Hepatology. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
121. DAHARI H , Perelson AS
     Hepatitis C virus kinetics in chimeric mice during antiviral therapy.
     Hepatology. 2007;.
     PubMed     Related articles   
     
     
     
122. MCHUTCHISON JG , Bacon BR, Gordon SC, Lawitz E, et al
     Phase 1B, randomized, double-blind, dose-escalation trial of CPG 10101 in patients with chronic hepatitis C virus.
     Hepatology. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
123. FELD JJ , Nanda S, Huang Y, Chen W, et al
     Hepatic gene expression during treatment with peginterferon and ribavirin: Identifying molecular pathways for treatment response.
     Hepatology. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
124. CHANG JJ , Thompson AJ, Visvanathan K, Kent SJ, et al
     The phenotype of hepatitis B virus-specific T cells differ in the liver and blood in chronic hepatitis B virus infection.
     Hepatology. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
125. SMITH J , Han SH
     "True" weight-based dosing versus "flat" dosing of ribavirin: will the WIN-R please come forward?
     Hepatology. 2007;46:953-6.
     PubMed     Related articles   
     
     
     September 2007
126. JACOBSON IM , Brown RS Jr, McCone J, Black M, et al
     Impact of weight-based ribavirin with peginterferon alfa-2b in african americans with hepatitis C virus genotype 1.
     Hepatology. 2007;46:982-990.
     PubMed     Related articles    Abstract available
     
     
     
127. WORMAN HJ
     Re-evaluating the use of growth factors as adjuvant treatment of chronic hepatitis C.
     Hepatology. 2007;46:1307-1308.
     PubMed     Related articles    Abstract available
     
     
     
128. GAETA GB , Stroffolini T, Smedile A, Niro G, et al
     Hepatitis delta in Europe: Vanishing or refreshing?
     Hepatology. 2007;46:1312-1313.
     PubMed     Related articles    Abstract available
     
     
     
129. JACOBSON IM , Brown RS Jr, Freilich B, Afdhal N, et al
     Peginterferon alfa-2b and weight-based or flat-dose ribavirin in chronic hepatitis C patients: A randomized trial.
     Hepatology. 2007;46:971-981.
     PubMed     Related articles    Abstract available
     
     
     
130. SZABO G , Chang S, Dolganiuc A
     Altered innate immunity in chronic hepatitis C infection: Cause or effect?
     Hepatology. 2007;.
     PubMed     Related articles   
     
     
     
131. GEPPERT CM , Arora S
     Widening the door: The evolution of hepatitis C treatment in patients with psychiatric disorders.
     Hepatology. 2007;.
     PubMed     Related articles   
     
     
     
132. XU R , Zhang X, Zhang W, Fang Y, et al
     Association of human APOBEC3 cytidine deaminases with the generation of hepatitis virus B x antigen mutants and hepatocellular carcinoma.
     Hepatology. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
133. FORESTIER N , Reesink HW, Weegink CJ, McNair L, et al
     Antiviral activity of telaprevir (VX-950) and peginterferon alfa-2a in patients with hepatitis C.
     Hepatology. 2007;46:640-8.
     PubMed     Related articles    Abstract available
     
     
     
134. MODI AA , Hoofnagle JH
     New therapies for hepatitis C.
     Hepatology. 2007;46:615-7.
     PubMed     Related articles   
     
     
     
135. TACKE F , Trautwein C
     Efficient recombinant hepatitis E virus vaccine: Mission accomplished?
     Hepatology. 2007;46:941-3.
     PubMed     Related articles    Abstract available
     
     
     
136. GARCIA-SAMANIEGO J , Forns X
     Hepatitis C virus and human immunodeficiency virus: The Un-Won Battle.
     Hepatology. 2007;46:611-4.
     PubMed     Related articles   
     
     
     August 2007
137. VERMA S , Torbenson M, Thuluvath PJ
     The impact of ethnicity on the natural history of autoimmune hepatitis.
     Hepatology. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
138. SHAHEEN AA , Myers RP
     Diagnostic accuracy of the aspartate aminotransferase-to-platelet ratio index for the prediction of hepatitis C-related fibrosis: A systematic review.
     Hepatology. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
139. NOVICK DM , Kreek MJ
     Hepatitis C treatment, subcutaneous naltrexone implants, and methadone maintenance treatment.
     Hepatology. 2007;.
     PubMed     Related articles   
     
     
     
140. LIAW YF
     Viral load in hepatitis B e antigen-negative carriers with normal aminotransferase level.
     Hepatology. 2007;.
     PubMed     Related articles   
     
     
     
141. VOLKMANN X , Fischer U, Bahr MJ, Ott M, et al
     Increased hepatotoxicity of tumor necrosis factor-related apoptosis-inducing ligand in diseased human liver.
     Hepatology. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
142. STOUT-DELGADO HW , Getachew Y, Rogers TE, Miller BC, et al
     The role of serpinb9/serine protease inhibitor 6 in preventing granzyme B-dependent hepatotoxicity.
     Hepatology. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
143. LIU XE , Desmyter L, Gao CF, Laroy W, et al
     N-glycomic changes in hepatocellular carcinoma patients with liver cirrhosis induced by hepatitis B virus.
     Hepatology. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
144. KIEFFER TL , Sarrazin C, Miller JS, Welker MW, et al
     Telaprevir and pegylated interferon-alpha-2a inhibit wild-type and resistant genotype 1 hepatitis C virus replication in patients.
     Hepatology. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
145. BRUNO S , Crosignani A, Maisonneuve P, Rossi S, et al
     Hepatitis C virus genotype 1b as a major risk factor associated with hepatocellular carcinoma in patients with cirrhosis: A seventeen-year prospective cohort study.
     Hepatology. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
146. SAAB S , Dong MH, Joseph TA, Tong MJ, et al
     Hepatitis B prophylaxis in patients undergoing chemotherapy for lymphoma: A decision analysis model.
     Hepatology. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
147. HUI CK , Leung N, Shek TW, Yao H, et al
     Sustained disease remission after spontaneous HBeAg seroconversion is associated with reduction in fibrosis progression in chronic hepatitis B Chinese patients.
     Hepatology. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
148. MOOKERJEE RP , Stadlbauer V, Lidder S, Wright GA, et al
     Neutrophil dysfunction in alcoholic hepatitis superimposed on cirrhosis is reversible and predicts the outcome.
     Hepatology. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
149. BONORINO P , Leroy V, Dufeu-Duchesne T, Tongiani-Dashan S, et al
     Features and distribution of CD8 T cells with human leukocyte antigen class I-specific receptor expression in chronic hepatitis C.
     Hepatology. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
150. MONTANO-LOZA AJ , Carpenter HA, Czaja AJ
     Features associated with treatment failure in type 1 autoimmune hepatitis and predictive value of the model of end-stage liver disease.
     Hepatology. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
151. NATTERMANN J , Vogel M, Berg T, Danta M, et al
     Effect of the interleukin-6 C174G gene polymorphism on treatment of acute and chronic hepatitis C in human immunodeficiency virus coinfected patients.
     Hepatology. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
152. SCHAEFER M , Hinzpeter A, Mohmand A, Janssen G, et al
     Hepatitis C treatment in "difficult-to-treat" psychiatric patients with pegylated interferon-alpha and ribavirin: Response and psychiatric side effects.
     Hepatology. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
153. BINDER M , Kochs G, Bartenschlager R, Lohmann V, et al
     Hepatitis C virus escape from the interferon regulatory factor 3 pathway by a passive and active evasion strategy.
     Hepatology. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
154. PERSICO M , Capasso M, Persico E, Svelto M, et al
     Suppressor of cytokine signaling 3 (SOCS3) expression and hepatitis C virus-related chronic hepatitis: Insulin resistance and response to antiviral therapy.
     Hepatology. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
155. LANFORD RE , Guerra B, Bigger CB, Lee H, et al
     Lack of response to exogenous interferon-alpha in the liver of chimpanzees chronically infected with hepatitis C virus.
     Hepatology. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
156. STROFFOLINI T , Gaeta GB, Mele A
     AASLD practice guidelines on chronic hepatitis B and HBV infection in Italy.
     Hepatology. 2007;46:608-9.
     PubMed     Related articles   
     
     
     
157. FAZILI J , Bader TF, Tierney W
     Treating acute hepatitis B.
     Hepatology. 2007;46:607-8.
     PubMed     Related articles   
     
     
     
158. PAPATHEODORIDIS GV , Manesis EK, Manolakopoulos S, Archimandritis AJ, et al
     Serum hepatitis B virus-DNA cutoff levels in hepatitis B e antigen-negative chronic hepatitis B virus infection.
     Hepatology. 2007;46:606-7.
     PubMed     Related articles   
     
     
     
159. LASKUS T , Wilkinson J, Karim R, Mack W, et al
     Hepatitis C virus quasispecies in HIV-infected women: Role of injecting drug use and highly active antiretroviral therapy (HAART).
     Hepatology. 2007;46:359-70.
     PubMed     Related articles    Abstract available
     
     
     
160. BEDOSSA P , Moucari R, Chelbi E, Asselah T, et al
     Evidence for a role of nonalcoholic steatohepatitis in hepatitis C: A prospective study.
     Hepatology. 2007;46:380-7.
     PubMed     Related articles    Abstract available
     
     
     
161. ROSEN HR , Weston SJ, Im K, Yang H, et al
     Selective decrease in hepatitis C virus-specific immunity among African Americans and outcome of antiviral therapy.
     Hepatology. 2007;46:350-8.
     PubMed     Related articles    Abstract available
     
     
     
162. ELSHARKAWY AM , Mann DA
     Nuclear factor-kappaB and the hepatic inflammation-fibrosis-cancer axis.
     Hepatology. 2007;46:590-7.
     PubMed     Related articles    Abstract available
     
     
     July 2007
163. LEWIN M , Poujol-Robert A, Boelle PY, Wendum D, et al
     Diffusion-weighted magnetic resonance imaging for the assessment of fibrosis in chronic hepatitis C.
     Hepatology. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
164. DERKOW K , Loddenkemper C, Mintern J, Kruse N, et al
     Differential priming of CD8 and CD4 T-cells in animal models of autoimmune hepatitis and cholangitis.
     Hepatology. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
165. TSENG FC , O'brien TR, Zhang M, Kral AH, et al
     Seroprevalence of hepatitis C virus and hepatitis B virus among San Francisco injection drug users, 1998 to 2000.
     Hepatology. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
166. AKUTA N , Suzuki F, Kawamura Y, Yatsuji H, et al
     Amino acid substitutions in the hepatitis C virus core region are the important predictor of hepatocarcinogenesis.
     Hepatology. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
167. STOOP JN , Woltman AM, Biesta PJ, Kusters JG, et al
     Tumor necrosis factor alpha inhibits the suppressive effect of regulatory T cells on the hepatitis B virus-specific immune response.
     Hepatology. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
168. DIAMOND DL , Jacobs JM, Paeper B, Proll SC, et al
     Proteomic profiling of human liver biopsies: Hepatitis C virus-induced fibrosis and mitochondrial dysfunction.
     Hepatology. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
169. FELD JJ , Ayers M, El-Ashry D, Mazzulli T, et al
     Hepatitis B virus DNA prediction rules for hepatitis B e antigen-negative chronic hepatitis B.
     Hepatology. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
170. POCKROS PJ , Schiff ER, Shiffman ML, McHutchison JG, et al
     Oral IDN-6556, an antiapoptotic caspase inhibitor, may lower aminotransferase activity in patients with chronic hepatitis C.
     Hepatology. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
171. CHAN HL , Ren H, Chow WC, Wee T, et al
     Randomized trial of interferon beta-1a with or without ribavirin in Asian patients with chronic hepatitis C.
     Hepatology. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
172. LIN SY , Chang ET, So SK
     Why we should routinely screen Asian American adults for hepatitis B: A cross-sectional study of Asians in California.
     Hepatology. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
173. YOO BC , Kim JH, Kim TH, Koh KC, et al
     Clevudine is highly efficacious in hepatitis B e antigen-negative chronic hepatitis B with durable off-therapy viral suppression.
     Hepatology. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
174. PINEDA JA , Garcia-Garcia JA, Aguilar-Guisado M, Rios-Villegas MJ, et al
     Clinical progression of hepatitis C virus-related chronic liver disease in human immunodeficiency virus-infected patients undergoing highly active antiretroviral therapy.
     Hepatology. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
175. SCHIAVON LL , Schiavon JL, Carvalho Filho RJ, Sampaio JP, et al
     Simple blood tests as noninvasive markers of liver fibrosis in hemodialysis patients with chronic hepatitis C virus infection.
     Hepatology. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
176. UMEMURA T , Zen Y, Hamano H, Kawa S, et al
     Immunoglobin G4-hepatopathy: Association of immunoglobin G4-bearing plasma cells in liver with autoimmune pancreatitis.
     Hepatology. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
177. HUI CK , Leung N, Yuen ST, Zhang HY, et al
     Natural history and disease progression in Chinese chronic hepatitis B patients in immune-tolerant phase.
     Hepatology. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
178. CHEN Y , Wei H, Sun R, Dong Z, et al
     Increased susceptibility to liver injury in hepatitis B virus transgenic mice involves NKG2D-ligand interaction and natural killer cells.
     Hepatology. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
179. BAUMERT TF , Rosler C, Malim MH, von Weizsacker F, et al
     Hepatitis B virus DNA is subject to extensive editing by the human deaminase APOBEC3C.
     Hepatology. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
180. JHAVERI R , Murray N
     An omission in the AASLD Practice Guidelines on Chronic Hepatitis B.
     Hepatology. 2007;46:280.
     PubMed     Related articles   
     
     
     
181. HALFON P , Penaranda G, Renou C, Bourliere M, et al
     External validation of FibroIndex.
     Hepatology. 2007;46:280-1.
     PubMed     Related articles   
     
     
     
182. LOK AS , Zoulim F, Locarnini S, Bartholomeusz A, et al
     Antiviral drug-resistant HBV: standardization of nomenclature and assays and recommendations for management.
     Hepatology. 2007;46:254-65.
     PubMed     Related articles    Abstract available
     
     
     June 2007
183. BUSTER EH , Hansen BE, Buti M, Delwaide J, et al
     Peginterferon alpha-2b is safe and effective in HBeAg-positive chronic hepatitis B patients with advanced fibrosis.
     Hepatology. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
184. FERNANDES F , Poole DS, Hoover S, Middleton R, et al
     Sensitivity of hepatitis C virus to cyclosporine A depends on nonstructural proteins NS5A and NS5B.
     Hepatology. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
185. STEINMANN E , Whitfield T, Kallis S, Dwek RA, et al
     Antiviral effects of amantadine and iminosugar derivatives against hepatitis C virus.
     Hepatology. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
186. HINES IN , Kremer M, Isayama F, Perry AW, et al
     Impaired liver regeneration and increased oval cell numbers following T cell-mediated hepatitis.
     Hepatology. 2007;46:229-241.
     PubMed     Related articles    Abstract available
     
     
     
187. WU WK , Duh MS, Lefebvre P
     Is there a difference in the cost-effectiveness of erythropoietic therapies for the treatment of anemia in patients receiving HCV combination therapy?
     Hepatology. 2007;46:283.
     PubMed     Related articles   
     
     
     
188. BEARD MR , Warner FJ
     Claudin-1, a new junction in the hepatitis C virus entry pathway.
     Hepatology. 2007;46:277-279.
     PubMed     Related articles   
     
     
     
189. SPIEGEL BM , Bolus R, Han S, Tong M, et al
     Development and validation of a disease-targeted quality of life instrument in chronic hepatitis B: The hepatitis B quality of life instrument, version 1.0.
     Hepatology. 2007;46:113-121.
     PubMed     Related articles    Abstract available
     
     
     
190. MATSUZAKI K , Murata M, Yoshida K, Sekimoto G, et al
     Chronic inflammation associated with hepatitis C virus infection perturbs hepatic transforming growth factor beta signaling, promoting cirrhosis and hepatocellular carcinoma.
     Hepatology. 2007;46:48-57.
     PubMed     Related articles    Abstract available
     
     
     
191. CUA IH , Hui JM, Bandara P, Kench JG, et al
     Insulin resistance and liver injury in hepatitis C is not associated with virus-specific changes in adipocytokines.
     Hepatology. 2007;46:66-73.
     PubMed     Related articles    Abstract available
     
     
     
192. HERKEL J , Manns MP, Lohse AW
     Selenocysteine, soluble liver antigen/liver-pancreas, and autoimmune hepatitis.
     Hepatology. 2007;46:275-277.
     PubMed     Related articles    Abstract available
     
     
     
193. DAHARI H , Ribeiro RM, Perelson AS
     Triphasic decline of hepatitis C virus RNA during antiviral therapy.
     Hepatology. 2007;46:16-21.
     PubMed     Related articles    Abstract available
     
     
     
194. CHOU YC , Chen ML, Hu CP, Chen YL, et al
     Transforming growth factor-beta1 suppresses hepatitis B virus replication primarily through transcriptional inhibition of pregenomic RNA.
     Hepatology. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
195. MHAMDI M , Funk A, Hohenberg H, Will H, et al
     Assembly and budding of a hepatitis B virus is mediated by a novel type of intracellular vesicles.
     Hepatology. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
196. PICCOLI C , Scrima R, Quarato G, D'Aprile A, et al
     Hepatitis C virus protein expression causes calcium-mediated mitochondrial bioenergetic dysfunction and nitro-oxidative stress.
     Hepatology. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
197. BACKUS LI , Boothroyd DB, Phillips BR, Mole LA, et al
     Predictors of response of U.S. veterans to treatment for the hepatitis C virus.
     Hepatology. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
198. VALLET-PICHARD A , Mallet V, Nalpas B, Verkarre V, et al
     FIB-4: An inexpensive and accurate marker of fibrosis in HCV infection. comparison with liver biopsy and fibrotest.
     Hepatology. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
199. SU JM , Lai XM, Lan KH, Li CP, et al
     X protein of hepatitis B virus functions as a transcriptional corepressor on the human telomerase promoter.
     Hepatology. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
200. LONGHI MS , Hussain MJ, Bogdanos DP, Quaglia A, et al
     Cytochrome P450IID6-specific CD8 T cell immune responses mirror disease activity in autoimmune hepatitis type 2.
     Hepatology. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
201. SHIFFMAN ML , Salvatore J, Hubbard S, Price A, et al
     Treatment of chronic hepatitis C virus genotype 1 with peginterferon, ribavirin, and epoetin alpha.
     Hepatology. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
202. TIMM J , Li B, Daniels MG, Bhattacharya T, et al
     Human leukocyte antigen-associated sequence polymorphisms in hepatitis C virus reveal reproducible immune responses and constraints on viral evolution.
     Hepatology. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
203. SHERMAN KE , Peters M, Koziel MJ
     HIV and liver disease forum: conference proceedings.
     Hepatology. 2007;45:1566-77.
     PubMed     Related articles   
     
     
     May 2007
204. YEO W , Mo FK, Chan SL, Leung NW, et al
     Hepatitis B viral load predicts survival of HCC patients undergoing systemic chemotherapy.
     Hepatology. 2007;45:1382-1389.
     PubMed     Related articles    Abstract available
     
     
     
205. LIAN Z , Liu J, Wu M, Wang HY, et al
     Hepatitis B x antigen up-regulates vascular endothelial growth factor receptor 3 in hepatocarcinogenesis.
     Hepatology. 2007;45:1390-1399.
     PubMed     Related articles    Abstract available
     
     
     
206. WERTHEIMER AM , Polyak SJ, Leistikow R, Rosen HR, et al
     Engulfment of apoptotic cells expressing HCV proteins leads to differential chemokine expression and STAT signaling in human dendritic cells.
     Hepatology. 2007;45:1422-1432.
     PubMed     Related articles    Abstract available
     
     
     
207. SU TH , Kao JH, Chen DS
     APRI-M6 for predicting long-term outcome of chronic hepatitis C patients after interferon-based therapy: More questions than answers.
     Hepatology. 2007;45:1586-1587.
     PubMed     Related articles   
     
     
     
208. JAESCHKE H , Liu J
     Neutrophil depletion protects against murine acetaminophen hepatotoxicity: Another perspective.
     Hepatology. 2007;45:1588-1589.
     PubMed     Related articles   
     
     
     
209. CHRISTEN V , Treves S, Duong FH, Heim MH, et al
     Activation of endoplasmic reticulum stress response by hepatitis viruses up-regulates protein phosphatase 2A.
     Hepatology. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
210. ULCICKAS YOOD M , Quesenberry CP Jr, Guo D, Caldwell C, et al
     Incidence of non-Hodgkin's lymphoma among individuals with chronic hepatitis B virus infection.
     Hepatology. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
211. YEE LJ , Tang YM, Kleiner DE, Wang D, et al
     Myxovirus-1 and protein kinase haplotypes and fibrosis in chronic hepatitis C virus.
     Hepatology. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
212. CHEVALIEZ S , Bouvier-Alias M, Brillet R, Pawlotsky JM, et al
     Overestimation and underestimation of hepatitis C virus RNA levels in a widely used real-time polymerase chain reaction-based method.
     Hepatology. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
213. DONG Z , Zhang J, Sun R, Wei H, et al
     Impairment of liver regeneration correlates with activated hepatic NKT cells in HBV transgenic mice.
     Hepatology. 2007;45:1400-1412.
     PubMed     Related articles    Abstract available
     
     
     
214. NG TI , Mo H, Pilot-Matias T, He Y, et al
     Identification of host genes involved in hepatitis C virus replication by small interfering RNA technology.
     Hepatology. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
215. LOUVET A , Naveau S, Abdelnour M, Ramond MJ, et al
     The Lille model: A new tool for therapeutic strategy in patients with severe alcoholic hepatitis treated with steroids.
     Hepatology. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
216. LOK AS , McMahon BJ
     Corrections to AASLD guidelines on chronic hepatitis B.
     Hepatology. 2007;.
     PubMed     Related articles   
     
     
     
217. MALMASSARI SL , Deng Q, Fontaine H, Houitte D, et al
     Impact of hepatitis B virus basic core promoter mutations on T cell response to an immunodominant HBx-derived epitope.
     Hepatology. 2007;45:1199-209.
     PubMed     Related articles    Abstract available
     
     
     
218. PAZIENZA V , Clement S, Pugnale P, Conzelman S, et al
     The hepatitis C virus core protein of genotypes 3a and 1b downregulates insulin receptor substrate 1 through genotype-specific mechanisms.
     Hepatology. 2007;45:1164-71.
     PubMed     Related articles    Abstract available
     
     
     
219. FONTANA RJ , Bieliauskas LA, Lindsay KL, Back-Madruga C, et al
     Cognitive function does not worsen during pegylated interferon and ribavirin retreatment of chronic hepatitis C.
     Hepatology. 2007;45:1154-63.
     PubMed     Related articles    Abstract available
     
     
     
220. LIN CL , Liao LY, Liu CJ, Yu MW, et al
     Hepatitis B viral factors in HBeAg-Negative carriers with persistently normal serum alanine aminotransferase levels.
     Hepatology. 2007;45:1193-8.
     PubMed     Related articles    Abstract available
     
     
     
221. YOO BC , Kim JH, Chung YH, Lee KS, et al
     Twenty-four-week clevudine therapy showed potent and sustained antiviral activity in HBeAg-positive chronic hepatitis B.
     Hepatology. 2007;45:1172-8.
     PubMed     Related articles    Abstract available
     
     
     
222. WESTIN J , Hellstrand K, Alsio A, Ydreborg M, et al
     Impact of disease severity on outcome of antiviral therapy in treatment-naive patients with chronic hepatitis C.
     Hepatology. 2007;45:1333-4.
     PubMed     Related articles   
     
     
     
223. WEDEMEYER H , Heidrich B, Manns MP
     Hepatitis D virus infection-Not a vanishing disease in Europe!
     Hepatolog